Clearmind Medicine Inc Sustainability Reports
Clearmind Medicine Inc. is a clinical-stage biotechnology company focused on developing novel psychedelic-derived therapeutics. Its primary focus is on regulating binge behavior and treating health conditions such as alcohol use disorder.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
LEI: 8945006FVE3FLKX9BN50
1 reports from 2024 to 2024
Company Profile
Clearmind Medicine Inc. is a clinical-stage biotechnology company focused on developing novel psychedelic-derived therapeutics. Its primary focus is on regulating binge behavior and treating health conditions such as alcohol use disorder.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
